Daniël Pipeleers
About
In The Last Decade
Daniël Pipeleers
361 papers receiving 20.3k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Surgery 15.8k
- Endocrinology, Diabetes and Metabolism 9.8k
- Genetics 9.7k
- Molecular Biology 6.7k
- Immunology 2.0k
Countries citing papers authored by Daniël Pipeleers
This map shows the geographic impact of Daniël Pipeleers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniël Pipeleers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniël Pipeleers more than expected).
Fields of papers citing papers by Daniël Pipeleers
This network shows the impact of papers produced by Daniël Pipeleers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniël Pipeleers. The network helps show where Daniël Pipeleers may publish in the future.
Co-authorship network of co-authors of Daniël Pipeleers
This figure shows the co-authorship network connecting the top 25 collaborators of Daniël Pipeleers. A scholar is included among the top collaborators of Daniël Pipeleers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniël Pipeleers. Daniël Pipeleers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 3 | |
| 3 | 11 | |
| 4 | Pre-existing insulin autoantibodies predict efficacy of otelixizumab in preserving residual beta cell function in recent-onset type 1 diabetes | 4 |
| 5 | Seroconversion to persistent islet autoantibody-positivity can occur at all ages, is best predicted by glutamate decarboxylase antibodies and is strongly associated with progression to diabetes | 1 |
| 6 | Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes breakdown → | 964 |
| 7 | AUTOREACTIVE CD8 T CELLS ASSOCIATED WITH BETA-CELL DESTRUCTION IN TYPE 1 DIABETES | 8 |
| 8 | Role of locally released glucagon in the insulin secretory response from the intact pancreas | 1 |
| 9 | 6 | |
| 10 | 75 | |
| 11 | 93 | |
| 12 | 272 | |
| 13 | CHRONIC EXPOSURE OF HUMAN PANCREATIC BETA-CELLS TO HIGH GLUCOSE INCREASES THEIR FUNCTIONAL-ACTIVITY BUT DECREASES THEIR SENSITIVITY TO ACUTE REGULATION BY GLUCOSE | 2 |
| 14 | Pancreatic ß-cells are heterogeneous in their capacity to metabolise glucose | 2 |
| 15 | 27 | |
| 16 | Physiological inhibition of hexokinase in intact islets | 3 |
| 17 | Alloxan uptake by pancreatic B and non-B islet cells | 4 |
| 18 | Glucose metabolism and insulin release: the role of glyceraldehyde | 4 |
| 19 | 6 | |
| 20 | The possible role of a glycolytic metabolite as a signal for glucose-induced insulin biosynthesis and release | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.